|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | High Density Tungsten-CopperLiquid Phase Sintered Composites From Coreduced Oxide Pow-ders显示文摘 | Sebastian K V Tendolker G S | 1979 | Powder Metall&Powder Tech1979，15，1： | 1 |
| 2 | High density tungsten-copper liquid phase sintered composite from coreduced oxide powders显示文摘 | Tendolkar G S | 1979 | International Journal of Powder Metallurgy and Powder Technology1979，15，1： | 1 |
| 3 | Impact of oil contamination and biostimulation on the diversity of indigenous bacterial communities in soil microcosms显示文摘 | Evans F F Rosado A S Sebastian G V | 2004 | FEMS Microbiol Ecol2004，49，29： | 1 |
| 4 | Presentation of 2 cases of sudden deafness in patients with sickle-cell anemia and trait显示文摘 | Garcia C Sebastian G Morant V | 2002 | Acta Otorrinolaringol Esp2002，53，5： | 1 |
| 5 | Impact of oil contamination and biosfimulation on the diversity of indigenous bacterial communities in soil microcosms显示文摘 | EVANS F F ROSADO A S SEBASTIAN G V | 2004 | FEMS Microbiol Ecol2004，48，2： | 1 |
| 6 | High density tungsten- copper liquid phase sintered composites from coreduced oxide powders 显示文摘 | Sebastian K V Tendolker G S | 1979 | Powder Metall & Powder Tech1979，15，1： | 1 |
| 7 | Degradation of agranular base under a flexible pavement:DEM simulation显示文摘 | LUIS E V SEBASTIAN L G KEVIN H | 2006 | International Journal of Geomechanics2006，6，6： | 1 |
| 8 | Production of biosurfactants from Pseudomonas aeruginosa PAl isolated in oil environments 显示文摘 | SANTA A L M SEBASTIAN G V MENEZES E P | 2002 | Braz J Chem Eng2002，19，： | 1 |
| 9 | Enhanced oxygen reduction activity and durability of Pt catalysts supported on carbon nanofibers 显示文摘 | Sebastian D Ruiza A G Suelves I Moliner R Lazaro M J Baglio V Stassi A Arico A S | 2012 | Applied Catalysis B: Environmental2012，115，： | 1 |
| 10 | High density tungsten-copper liquid phase sintered composites from coreduced oxide powders显示文摘 | Sebastian K V Tendolkar G S | 1979 | Int J Powder Metall Powder Technol1979，15，1： | 1 |
| 11 | An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches: Efficacy, tolerability and compliance with label dose administration directions显示文摘 | Dr Elliot V Hersh Dr Sebastian G Ciancio Dr Arthur S Kuperstein | 2013 | J Am Dent Assoo2013，144，5： | 1 |
| 12 | Production of biosurfactants from Pseudomonas aeruginosa PAl isolated in oil environments显示文摘 | Santa Anna L M Sebastian G V Menezes E P | 2002 | Braz J Chem Eng2002，19，： | 1 |
| 13 | Budd-Chiari syndrome in myeloproliferative neoplasms:A review of literature显示文摘Myeloproliferative neoplasms(MPNs)are defined as clonal disorders of the hematopoietic stem cell in which an exaggerated production of terminally differentiated myeloid cells occurs.Classical,Philadelphia-negative MPNs,i.e.,polycythemia vera,essential thrombocythemia and primary myelofibrosis,exhibit a propensity towards the development of thrombotic complications that can occur in unusual sites,e.g.,portal,splanchnic or hepatic veins,the placenta or cerebral sinuses.The pathogenesis of thrombotic events in MPNs is complex and requires an intricate mechanism involving endothelial injury,stasis,elevated leukocyte adhesion,integrins,neutrophil extracellular traps,somatic mutations(e.g.,the V617F point mutation in the JAK2 gene),microparticles,circulating endothelial cells,and other factors,to name a few.Herein,we review the available data on Budd-Chiari syndrome in Philadelphia-negative MPNs,with a particular focus on its epidemiology,pathogenesis,histopathology,risk factors,classification,clinical presentation,diagnosis,and management. | Mihnea-Alexandru Găman Matei-Alexandru Cozma Muhammad Romail Manan Bahadar S Srichawla Arkadeep Dhali Sajjad Ali Ahmed Nahian Andrew C Elton L V Simhachalam Kutikuppala Richard Christian Suteja Sebastian Diebel Amelia Maria Găman Camelia Cristina Diaconu | 2023 | World Journal of Clinical Oncology2023，14，3： | 0 |
| 14 | Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research显示文摘Background Non-interventional large-scale research on real-world patients who had a stroke requires the use of multiple data sources ensuring access to longitudinal data from large populations with clinically-detailed information.We sought to establish a framework for longitudinal research on patients hospitalised with stroke by linking information-rich,deidentified inpatient data from the Paul Coverdell National Acute Stroke Program(PCNASP)to commercial and Medicare Advantage longitudinal claims data.Methods All stroke admissions in PCNASP between 2008 and 2015 were evaluated for linkage to longitudinal claims from a commercial insurer using an algorithm based on six available common data fields(patient age,gender,admission date,discharge date,discharge diagnosis and state)and a hospital match.We evaluated the linkage quality(via the percentage of unique records in the linked dataset)and the representativeness of the linked population.We also described medical history,stroke severity and patterns of medication use among the PCNASP-claims linked cohort.Results The linkage produced uniqueness equal to 99.1%.We identified 5644 linked and 98896 unlinked patients who had an ischaemic stroke hospitalisation in claims data.Linked patients were younger than unlinked(69.7 vs 72.5 years),but otherwise similar by medical history,prestroke medication use or lab values.Stroke severity was mild and most patients were discharged home.Prestroke and discharge use of antihypertensive and statins in the PCNASP were greater than their use as measured by filled prescriptions in claims.Conclusions High-quality linkage between the PCNASP and commercial claims data is feasible.This linkage identified differences between reported or recommended versus actual out-of-hospital medication utilisation,highlighting the importance of longitudinal data availability for research aimed to improve the care of patients who had a stroke. | Elisabetta Patorno Sebastian Schneeweiss Mary G George Xin Tong Jessica M Franklin Ajinkya Pawar Helen Mogun Lidia M V R Moura Lee H Schwamm | 2022 | Stroke & Vascular Neurology2022，7，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员